Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
- PMID: 32622830
- DOI: 10.1016/j.kint.2020.05.053
Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties
Abstract
In recent years, a substantial body of experimental and clinical work has been devoted to C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis. Despite the rapid accumulation of data, several uncertainties about these 2 rare forms of nephropathies persist. They concern their pathophysiology, classification, clinical course, relevance of biomarkers and of pathology findings, and assessment of the efficacy of the available therapies. The present review discusses the impact of these uncertainties on the clinical management of patients.
Keywords: C3 glomerulopathy; Ig-mediated membranoproliferative glomerulonephritis; complement.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous